Maze Therapeutics CSBO Sells: Reading Insider Moves
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Explore which bond types deliver superior after-tax yields in retirement, balancing tax effects and volatility to maximize net income.
27,946 articlesWhen a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Two Navy jets collided during an Idaho air show, and four crew members ejected safely. The incident triggered a base ...
NVIDIA stock struggled over the last week despite solid earnings. This guide breaks down the reasons behind the move ...
A trader alleges Polymarket unfairly resolved a market tied to MicroStrategy's bitcoin sale, claiming a post-deadline...
As roughly $1.8 billion in crypto options approach expiration on Deribit, traders weigh whether will markets continue...
A high-profile rift between two longtime mentors-turned-critics shines a light on how money, branding, and risk manag...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
Target's Circle Deal Days is more than a promo. It could be a lever for traffic, online sales, and margins. This arti...
A late-2025 Gallup poll finds only 28% of workers say now is a good time to find a quality job, with broad caution do...
When a company reports Q1 2026 results, the earnings call is where plans meet numbers. This guide explains how to rea...
IDT's (idt) 2026 earnings call will reveal how a diversified telecom and payments firm navigates macro headwinds. Thi...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...